Human papillomavirus self-sampling in Cameroon: Women's uncertainties over the reliability of the method are barriers to acceptance

Journal of Lower Genital Tract Disease

Volumn 17, Issue 3, 2013, Pages 235-241

  Berner, Amandine ^a   Hassel, Selim Ben ^a   Tebeu, Pierre Marie ^b   Untiet, Sarah ^c   Kengne Fosso, Gisèle ^b   Navarria, Isabelle ^c   Boulvain, Michel ^c   Vassilakos, Pierre ^d   Petignat, Patrick ^c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b University Hospitals   (Cameroon)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

Author keywords

Cameroon; Cervical cancer screening; HPV; Lowresource country; Self sampling

Indexed keywords

ADULT; AGED; ARTICLE; CAMEROON; CANCER SCREENING; CYTOLOGY; FEMALE; HUMAN; KNOWLEDGE; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT PREFERENCE; PHYSICIAN; PROSPECTIVE STUDY; QUESTIONNAIRE; RELIABILITY; SAMPLING; SCORING SYSTEM; UNCERTAINTY; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGED; CAMEROON; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SELF CARE; SPECIMEN HANDLING; YOUNG ADULT;

EID: 84880363768     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31826b7b51     Document Type: Article

References (30)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-25.
2. Tebeu PM, Petignat P, Mhawech-Fauceglia P. Gynecological malignancies in Maroua, Cameroon. Int J Gynaecol Obstet 2009;104:148-9.
3. Mbakop A, Essame Oyono JL, Ngbangako MC, Abondo A. Current epidemiology of cancers in Cameroon (Central Africa) [in French]. Bull Cancer 1992;79:1101-4.
4. Mbakop A, Yomi J, Yankeum J, Nkegoum B, Mouelle Sone A. Cancer localisation in men and women aged over 50 in Cameroon [in French]. Bull Cancer 1997;84:1119-22.
5. Robyr R, Nazeer S, Vassilakos P, Matute JC, Sando Z, Halle G, et al. Feasibility of cytology-based cervical cancer screening in rural Cameroon. Acta Cytol 2002;46:1110-6.
6. Sauvaget C, Fayette JM, Muwongede R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet 2008; 113:14-24.
7. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929-36.
8. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105:530-5.
9. Petignat P, Faltin D, Goffin F, Billieux MH, Stucki D, Sporri S, et al. Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma. Cancer 2005;105:126-32.
10. Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst 2012;104:178-88.
11. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmeron J, Uribe P, Velasco-Mondragon E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011;378:1868-73.
12. Petignat P, Vassilakos P. is it time to introduce HPV selfsampling for primary cervical cancer screening? J Natl Cancer Inst 2012;104:166-7.
13. Dzuba IG, Diaz EY, Allen B, Leonard YF, Lazcano-Ponce EC, Shah KV, et al. The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002;11:265-75.
14. Waller J, McCafferyK, Forrest S, SzarewskiA, Cadman L, Austin J, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006;13:208-13.
15. De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A, et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev 2008;17:2163-8.
16. Cuzick J, Clavel C, Petry KU, Meijer JC, Hoyer H, Ratnam S, et al. Overview of the European and North American studies onHPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101.
17. Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007;120:1505-10.
18. Barata PC, Mai V, Howlett R, Gagliardi AR, Stewart DE. Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention. J Psychosom Obstet Gynaecol 2008;29:251-7.
19. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC Jr. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) 2005;14:721-8.
20. Howard M, Lytwyn A, Lohfeld L, Redwood-Campbell L, Fowler N, Karwalajtys T. Barriers to acceptance of selfsampling for human papillomavirus across ethnolinguistic groups of women. Can J Public Health 2009;100:365-9.
21. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006;82:337-9.
22. Forrest S, McCaffery K, Waller J, Desai M, Szarewski A, Cadman L, et al. Attitudes to self-sampling for HPVamong Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screen 2004;11:85-8.
23. Barbee L, Kobetz E, Menard J, Cook N, Blanco J, Barton B, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control 2010;21:421-31.
24. Tisci S, Shen YH, Fife D, Huang J, Goycoolea J, Ma CP, et al. Patient acceptance of self-sampling for human papillomavirus in rural China. J Lower Gen Tract Dis 2003;7:107-16.
25. Mitchell S, Ogilvie G, Steinberg M, Sekikubo M, Biryabarema C, Money D. Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. Int J Gynaecol Obstet 2011;114:111-5.
26. Sanchaisuriya P, Pengsaa P, Sriamporn S, Schelp FP, Kritpetcharat O, Suwanrungruang K, et al. Experience with a self-administered device for cervical cancer screening by Thai women with different educational backgrounds. Asian Pac J Cancer Prev 2004;5:144-50.
27. Lack N, West B, Jeffries D, Ekpo G, Morison L, Soutter WP, et al. Comparison of non-invasive sampling methods for detection of HPV in rural African women. Sex Transm Infect 2005;81:239-41.
28. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002;55:435-9.
29. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directedV biologic concordance and women's preferences. Am J Obstet Gynecol 2002;186:365-73.
30. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen 2009;16:193-8.